Page last updated: 2024-08-23

amikacin and Lung Diseases

amikacin has been researched along with Lung Diseases in 55 studies

Research

Studies (55)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (10.91)	18.7374
1990's	8 (14.55)	18.2507
2000's	9 (16.36)	29.6817
2010's	15 (27.27)	24.3611
2020's	17 (30.91)	2.80

Authors

Authors	Studies
Burns, JL; Dudley, MN; Griffith, DC; King, P; Lomovskaya, O	1
Akkerman, OW; Aliberti, S; Altenburg, J; Arets, B; Chiron, R; Delaere, B; Essink, S; Gohy, S; Haarman, E; Henriette Zweijpfenning, SM; Hoefsloot, W; Lorent, N; McKew, G; Morgan, L; Schildkraut, J; van Braeckel, E; van Ingen, J; Wagner, D	1
Jhun, BW; Jo, KW; Kang, YA; Kwak, N; Park, J; Park, SY; Park, Y; Park, YE; Shim, TS; Yim, JJ	1
Brode, SK; Carlson, KF; Henkle, E; Ku, JH; Marino, M; Marras, TK; Winthrop, KL	1
Abadi, SSD; Aghababa, AA; Arabpour, E; Bostanghadiri, N; Centis, R; Farahbakhsh, M; Malekshahian, D; Migliori, GB; Nasiri, MJ; Sotgiu, G; Yazarlou, F; Zangiabadian, M	1
Chong, YP; Jo, KW; Kim, SM; Lee, HJ; Shim, TS	1
Ashizawa, N; Hirayama, T; Hosogaya, N; Ide, S; Ito, Y; Iwanaga, N; Izumikawa, K; Kido, T; Mukae, H; Obase, Y; Okano, S; Ozasa, M; Sakamoto, N; Takao, D; Takazono, T; Takeda, K; Takemoto, S; Tashiro, M; Yanagihara, K	1
Kagawa, T; Kanaoka, K; Kobayashi, T; Kurahara, Y; Maeda, Y; Tachibana, K; Takeuchi, N; Tanaka, Y; Tsuyuguchi, K; Yoshida, S	1
Daley, CL; Nguyen, MH	1
Del Parigi, A; Swenson, C	1
Shulha, J	1
Chang, CL; Chen, LC; Chien, JY; Hsueh, PR; Yu, CJ	1
Brown-Elliott, BA; Ciesielska, M; Codecasa, LR; Coulter, C; Flume, PA; Griffith, DE; Mange, KC; Marras, TK; Morimoto, K; Ruoss, SJ; Thomson, R; van Ingen, J; Wallace, RJ; Winthrop, KL; Yim, JJ; Yuen, DW	1
Dominic, C; Gill, LI; Tiberi, S	1
Daley, CL; Huh, HJ; Jeon, K; Jhun, BW; Kang, N; Kim, H; Koh, WJ; Kwon, OJ; Lee, NY	1
Hoy, SM	1
Addrizzo-Harris, DJ; Aksamit, TR; Brown-Elliott, BA; Ciesielska, M; Coulter, C; Field, SK; Flume, PA; Griffith, DE; Hoefsloot, W; Mange, KC; Morimoto, K; Thomson, R; van Ingen, J; Wallace, RJ; Winthrop, KL; Yuen, DW	1
Boeree, MJ; Danho, R; Hoefsloot, W; Kuipers, S; Pennings, LJ; Schildkraut, JA; Svensson, EM; van Ingen, J; Wertheim, HFL; Zweijpfenning, SMH	1
Addrizzo-Harris, DJ; Aksamit, TR; Codecasa, LR; Coulter, C; Eagle, G; Field, SK; Flume, PA; Griffith, DE; Hasegawa, N; Hill, AT; Loebinger, MR; Marras, TK; Morgan, L; Morimoto, K; Nezamis, J; O'Donnell, AE; Philley, JV; Ringshausen, FC; Ruoss, SJ; Thomson, R; van Ingen, J; Wallace, RJ; Winthrop, KL; Yim, JJ	1
Daley, CL; Olivier, KN	1
Laughon, BE; Lee, SFK; Lipman, M; McHugh, TD	1
Shirley, M	1
Dalcolmo, MP; Daley, CL; Eather, G; Gayoso, R; Hasegawa, N; Jhun, BW; Koh, WJ; Kwak, N; Namkoong, H; Park, J; Thomson, R; van Ingen, J; Yim, JJ; Zweijpfenning, SMH	1
Chen, PR; Tan, SY	1
Kuijper, EJ; van Ingen, J	1
Adderson, EE; Apiwattankul, N; Flynn, PM; Hayden, RT	1
Hashiguchi, N; Inoshima, I; Inoshima, N	1
Eather, GW; Ellender, CM; Law, DB; Thomson, RM	1
Asakura, T; Betsuyaku, T; Fujiwara, H; Hasegawa, N; Hoshino, Y; Ishii, M; Kurashima, A; Kurosaki, A; Morimoto, K; Namkoong, H; Nishimura, T; Sugiura, H; Suzuki, S; Tanaka, H; Tasaka, S; Yagi, K; Yamada, Y	1
Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK	1
Barthélémy, C; De Broucker, M; Décaudin, B; Dubreuil, L; Lannoy, D; Odou, MF; Odou, P; Poret, E; Simon, N	1
Huang, YC; Kao, CC; Lin, CF; Liu, MF; Liu, PY; Shen, GH; Shi, ZY	1
Bonne, S; Legout, L; Prevotat, A; Senneville, E; Veziris, N; Yazdanpanah, Y	1
Cabadak, H; Cağlar, K; Hizel, K; Külah, C	1
Cheze, S; De Puyfontaine, O; Leporrier, M; Macro, M; Pan, B; Reman, O; Toudic, F	1
Balci, I; Bayram, N; Celik, G; Dikensoy, O; Ekinci, E; Filiz, A; Zer, Y	1
Bazzi, P; Beretta, S; Braga, M; Casati, G; Crespi, V; Farina, C; Ferrarini, M; Pederzoli, M; Repaci, M	1
Alp, E; Aygen, B; Boiron, P; Couble, A; Doganay, M; Sumerkan, B; Tokgoz, B; Tucer, B; Yildiz, O	1
Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A	1
Davis, KK; Jacobs, SS; Kao, PN; Ruoss, SJ	1
Bock, BV; Edelstein, PH; Meyer, RD	1
Chan, CY; Cheng, AF; Li, MS; Tam, CM; Yew, WW	1
Baroni, A; Catalanotti, P; Contaldi, G; Imperatore, F; Luongo, C; Mangoni, G; Marmo, M; Rossi, F; Stefano, S; Tufano, MA	1
Itokazu, GS; Weinstein, RA	1
Baroni, A; Catalanotti, P; Filippelli, A; Imperatore, F; Luongo, C; Mangoni, G; Marmo, M; Matera, MG; Rossi, F	1
Aebischer, CC; Bettinelli, A; Bianchetti, MG; Truttmann, AC; von Vigier, RO; Wermuth, B; Zindler-Schmocker, K	1
De Kock, MA; Theron, FP	1
Bartlett, JG	1
Ramírez-Rivera, J; Rivera-Rivera, R	1
Singh, N; Yu, VL	1
Craig, WA; Ebert, SC; Redington, J	1
Aulicino, TM; Berkowitz, LB; duBouchet, L; Gombert, ME	1
Bertrand, H; Boulanger-Ferre, F; Descottes, B; Desport, JC; Devalois, B; Mercury, P; Peze, P; Sardin, B	1
Egner, E; Jipp, P; Reinold, HM; Ruppert, S; Schaal, KP; Schröter, G	1
Chambon, M; Economides, A; Fougerat, J; Loire, R; Vincent, M	1

Reviews

11 review(s) available for amikacin and Lung Diseases

Article	Year
Amikacin liposome and Mycobacterium avium complex: A systematic review. PloS one, 2022, Volume: 17, Issue:12 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Liposomes; Lung Diseases; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies	2022
Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start? Clinics in chest medicine, 2023, Volume: 44, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Lung Diseases; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Treatment Outcome	2023
Atypical mycobacterial infections - management and when to treat. Current opinion in pulmonary medicine, 2021, 05-01, Volume: 27, Issue:3 Topics: Amikacin; Animals; Antitubercular Agents; Humans; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tuberculosis	2021
Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use. Clinical drug investigation, 2021, Volume: 41, Issue:4 Topics: Administration, Inhalation; Adult; Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum	2021
New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease. Current opinion in pulmonary medicine, 2019, Volume: 25, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Clofazimine; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Liposomes; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nitroimidazoles; Oxazoles	2019
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease. Drugs, 2019, Volume: 79, Issue:5 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Humans; Liposomes; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Treatment Outcome; Young Adult	2019
The European respiratory journal, 2019, Volume: 54, Issue:1 Topics: Aged; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Databases, Factual; Female; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous	2019
Drug susceptibility testing of nontuberculous mycobacteria. Future microbiology, 2014, Volume: 9, Issue:9 Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Humans; Lung Diseases; Macrolides; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium kansasii; Nontuberculous Mycobacteria	2014
Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer. Journal of the Pediatric Infectious Diseases Society, 2015, Volume: 4, Issue:2 Topics: Adolescent; Amikacin; Anti-Infective Agents; Catheter-Related Infections; Child; Child, Preschool; Clarithromycin; Debridement; Female; Humans; Immunocompromised Host; Infant; Lung Diseases; Male; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Neoplasms; Retrospective Studies	2015
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:9 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2005
Successful treatment of pulmonary infection due to Mycobacterium chelonae: case report and review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14, Issue:1 Topics: Amikacin; Cefoxitin; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Lung Diseases; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Sputum; Tomography, X-Ray Computed	1992

Trials

6 trial(s) available for amikacin and Lung Diseases

Article	Year
Amikacin Liposome Inhalation Suspension for Annals of the American Thoracic Society, 2021, Volume: 18, Issue:7 Topics: Administration, Inhalation; Adult; Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Treatment Outcome	2021
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure. Chest, 2021, Volume: 160, Issue:3 Topics: Administration, Inhalation; Adult; Amikacin; Anti-Bacterial Agents; Bacteriological Techniques; Drug Monitoring; Female; Humans; Liposomes; Long Term Adverse Effects; Lung Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum; Treatment Outcome	2021
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by American journal of respiratory and critical care medicine, 2018, 12-15, Volume: 198, Issue:12 Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Female; Humans; Liposomes; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Treatment Outcome	2018
Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series. BMC infectious diseases, 2016, 08-09, Volume: 16 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Outpatients; Retrospective Studies; Sputum; Treatment Outcome	2016
Impact of infusion method on amikacin serum levels in humans. Pulmonary pharmacology & therapeutics, 2010, Volume: 23, Issue:4 Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Community-Acquired Infections; Female; Half-Life; Humans; Infusion Pumps; Infusions, Intravenous; Lung Diseases; Male; Middle Aged; Time Factors; Tissue Distribution	2010
Prospective comparative study of efficacy and toxicity of netilmicin and amikacin. Antimicrobial agents and chemotherapy, 1980, Volume: 17, Issue:2 Topics: Adult; Aged; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Gentamicins; Humans; Kanamycin; Lung Diseases; Male; Middle Aged; Netilmicin; Sepsis; Urinary Tract Infections	1980

Other Studies

38 other study(ies) available for amikacin and Lung Diseases

Article	Year
In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Aerosols; Anti-Bacterial Agents; Bacteria; Biofilms; Chronic Disease; Ciprofloxacin; Colony Count, Microbial; Cystic Fibrosis; Humans; Levofloxacin; Lung Diseases; Microbial Sensitivity Tests; Ofloxacin; Sputum	2010
Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study. Chest, 2022, Volume: 162, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria	2022
Treatment outcome of continuation of intravenous amikacin for Mycobacterium abscessus pulmonary disease with a persistent culture positivity after the treatment initiation. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:8 Topics: Amikacin; Anti-Bacterial Agents; Humans; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Retrospective Studies; Treatment Outcome	2022
Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3 Topics: Aged; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Macrolides; Male; Medicare; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifamycins; United States	2023
Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use. Microbiology spectrum, 2023, 06-15, Volume: 11, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Humans; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Streptomycin; Treatment Outcome	2023
A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:8 Topics: Aged; Amikacin; Anti-Bacterial Agents; Female; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Organizing Pneumonia; Pneumonia	2023
Management of dysphonia caused by amikacin liposome inhalation in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023, 08-01, Volume: 27, Issue:11 Topics: Amikacin; Anti-Bacterial Agents; Dysphonia; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection	2023
Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex. Mayo Clinic proceedings, 2020, Volume: 95, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous	2020
In reply-Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex. Mayo Clinic proceedings, 2020, Volume: 95, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous	2020
Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 98 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Taiwan; Young Adult	2020
Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease. Chest, 2021, Volume: 160, Issue:2 Topics: Administration, Inhalation; Aged; Amikacin; Anti-Bacterial Agents; Azithromycin; Clofazimine; Drug Therapy, Combination; Female; Humans; Imipenem; Lung Diseases; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Prospective Studies	2021
Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease. Chest, 2022, Volume: 161, Issue:2 Topics: Aged; Amikacin; Antitubercular Agents; Azithromycin; Biomarkers; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Stem Cells	2022
ALIS (Amikacin Liposome Inhalation Suspension): The Beginning of a Wonderland? American journal of respiratory and critical care medicine, 2018, 12-15, Volume: 198, Issue:12 Topics: Amikacin; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies	2018
[The treatment outcomes of 21 cases of rapidly growing mycobacteria related pulmonary disease]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2013, Volume: 36, Issue:3 Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome; Young Adult	2013
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION SUCCESSFULLY TREATED WITH SHORT-TERM CAM, AMK, AND IPM/cs FOLLOWED BY LONG-TERM ORAL CAM AND LVFX]. Kekkaku : [Tuberculosis], 2015, Volume: 90, Issue:6 Topics: Administration, Oral; Aged; Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Female; Humans; Imipenem; Levofloxacin; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria	2015
Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease. Respirology (Carlton, Vic.), 2016, Volume: 21, Issue:2 Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Amikacin; Anti-Bacterial Agents; Female; Hearing Loss; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Treatment Outcome; Vestibular Diseases	2016
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. American journal of respiratory and critical care medicine, 2009, Nov-01, Volume: 180, Issue:9 Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Liver; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Thrombocytopenia; Tomography, X-Ray Computed; Treatment Outcome	2009
Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Treatment Outcome	2010
[Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient]. Medecine et maladies infectieuses, 2011, Volume: 41, Issue:8 Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Lung Diseases; Middle Aged; Minocycline; Mycobacterium Infections, Nontuberculous; Tigecycline	2011
Pulmonary nocardiosis in a non-Hodgkin's lymphoma patient. Infection, 2002, Volume: 30, Issue:4 Topics: Adult; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Humans; Immunocompromised Host; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Nocardia asteroides; Nocardia Infections; Trimethoprim, Sulfamethoxazole Drug Combination	2002
[Concomitant pulmonary nocardiosis and Hodgkin's disease: importance of long-term treatment]. Revue de pneumologie clinique, 2002, Volume: 58, Issue:4 Pt 1 Topics: Adult; Amikacin; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Erythromycin; Hodgkin Disease; Humans; Imipenem; Long-Term Care; Lung Diseases; Male; Minocycline; Nocardia Infections	2002
First report of pulmonary Nocardia otitidiscaviarum infection in an immunocompetent patient from Turkey. International journal of clinical practice, 2004, Volume: 58, Issue:2 Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Humans; Lung Diseases; Male; Nocardia Infections; Tomography, X-Ray Computed; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	2004
Medical treatment for nocardial brain abscesses case report. Journal of neurology, 2005, Volume: 252, Issue:9 Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Imipenem; Lung Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Nocardia Infections; Shoulder; Trimethoprim, Sulfamethoxazole Drug Combination	2005
Nocardiosis in a teaching hospital in the Central Anatolia region of Turkey: treatment and outcome. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:6 Topics: Adult; Amikacin; Anti-Bacterial Agents; Brain Abscess; Causality; Ceftriaxone; Fatal Outcome; Female; Hospitals, Teaching; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Retrospective Studies; Turkey	2005
Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series. BMC pulmonary medicine, 2007, Feb-23, Volume: 7 Topics: Administration, Inhalation; Administration, Oral; Aged; Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Lung Diseases; Macrolides; Middle Aged; Mycobacterium avium-intracellulare Infection; Treatment Outcome	2007
Lack of activities of amikacin and sulphamethoxazole against Mycobacterium avium-intracellulare. International journal of clinical pharmacology research, 1993, Volume: 13, Issue:2 Topics: Adult; Aged; Amikacin; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Saliva; Sulfamethoxazole; Trimethoprim, Sulfamethoxazole Drug Combination	1993
[Effects of hyperbaric oxygenation in skin and pulmonary infections caused by Pseudomonas aeruginosa]. Minerva anestesiologica, 1996, Volume: 62, Issue:9 Topics: Amikacin; Animals; Anti-Bacterial Agents; Combined Modality Therapy; Hyperbaric Oxygenation; Lung Diseases; Male; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Skin Diseases, Bacterial	1996
Aerosolized antimicrobials: another look. Critical care medicine, 1998, Volume: 26, Issue:1 Topics: Aerosols; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cytokines; Humans; Lung; Lung Diseases; Nebulizers and Vaporizers; Respiration, Artificial; Tobramycin; Ventilators, Mechanical	1998
Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 1999,Spring, Volume: 26, Issue:1 Topics: Amikacin; Animals; Anti-Bacterial Agents; Combined Modality Therapy; Hyperbaric Oxygenation; Lung Diseases; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Skin Diseases, Bacterial	1999
Aminoglycosides and renal magnesium homeostasis in humans. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:6 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Electrolytes; Female; Homeostasis; Humans; Kidney; Lung Diseases; Magnesium; Male; Pseudomonas aeruginosa; Pseudomonas Infections	2000
Clinical experience with amikacin, a new aminoglycoside antibiotic. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1977, May-21, Volume: 51, Issue:21 Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Male; Middle Aged; Pseudomonas Infections	1977
Amikacin treatment of pulmonary infections involving gentamicin-resistant gram-negative bacilli. The American journal of medicine, 1977, Volume: 62, Issue:6 Topics: Amikacin; Bacteria; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Lung Diseases	1977
Infected bullae: a recognizable entity. Boletin de la Asociacion Medica de Puerto Rico, 1992, Volume: 84, Issue:1 Topics: Amikacin; Clindamycin; Corynebacterium; Corynebacterium Infections; Cysts; Drug Therapy, Combination; Humans; Lung; Lung Diseases; Male; Mezlocillin; Middle Aged; Radiography; Sputum	1992
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections. The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl C Topics: Amikacin; Animals; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Kidney; Klebsiella pneumoniae; Lung Diseases; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Specific Pathogen-Free Organisms; Thigh	1991
Therapy of pulmonary nocardiosis in immunocompromised mice. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:9 Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Cortisone; Female; Humans; Imipenem; Immunity, Cellular; Immunologic Deficiency Syndromes; Lung Diseases; Mice; Nocardia asteroides; Nocardia Infections; Sulfadiazine	1990
[Infectious complications after surgery of esophageal pathology. Apropos of 60 cases]. Cahiers d'anesthesiologie, 1989, Volume: 37, Issue:5 Topics: Aged; Amikacin; Bacterial Infections; Cefoxitin; Esophageal Diseases; Female; Gram-Negative Bacteria; Humans; Lung Diseases; Male; Middle Aged; Parenteral Nutrition; Postoperative Complications; Premedication; Prospective Studies; Urinary Tract Infections	1989
[Successful antibiotic treatment of a pulmonary infection with Nocardia asteroides (biovariety A3)]. Deutsche medizinische Wochenschrift (1946), 1988, Nov-18, Volume: 113, Issue:46 Topics: Aged; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Nocardia asteroides; Nocardia Infections; Opportunistic Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1988
[Lipid pneumonia and superinfection by Mycobacterium fortuitum. Apropos of a case]. Revue des maladies respiratoires, 1987, Volume: 4, Issue:6 Topics: Amikacin; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections; Penicillins; Pneumonia, Aspiration; Pneumonia, Lipid; Tomography, X-Ray Computed	1987